Session Introduction: Overcoming health disparities in precision medicine: Intersectional approaches in precision medicine.

Francisco M De La Vega¹, Kathleen C Barnes², Harris Bland³, Todd Edwards³, Keolu Fox⁴, Alexander Ioannidis⁵, Eimear Kenny⁶, Rasika A Mathias⁷, Bogdan Pasaniuc⁸, Jada Benn Torres⁹, Digna R Velez Edwards³

¹Galatea Bio, Inc., United States.

²Oxford Nanopore, Ltd., United States.

³Vanderbilt University Medical Center, United States.

⁴University of California San Diego, United States.

⁵University of California Santa Cruz, United States.

⁶Ichan School of Medicine at Mount Sinai, United States.

⁷National Institute of Allergy and Infectious Diseases, United States.

⁸University of California Los Angeles, United States.

⁹Vanderbilt University, United States.

PubMed DOI

Abstract

The following sections are included: Overview, Advancing multi-ancestry genetic research, Integrating social determinants of health to enhance genetic risk models, Methods to detect and mitigate disparities, Addressing Disparities in Adverse Drug Reactions, Conclusion, Acknowledgments,References.

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.